Skip to main content

Table 1 Selected criteria sets and satisfaction at baseline among 708 DESIR patients

From: Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates

Criteria set origin Patients ever satisfying criteria set (n) and percent of total (N = 708) Diagnosis and disease severity criteria
France n = 197 (27.8%) BASDAI ≥4
New York criteria for AS OR involvement of SJ OR spine by X-ray, CT or MRI
Physician’s Global Assessment ≥4
Germany n = 175 (24.7%) BASDAI ≥4
ASAS criteria
Positive MRI or Elevated CRPb (i.e., minimum 1 of 2 criteria)
Canada n = 169 (23.8%) BASDAI ≥4
Sacroiilitis or spinal inflammation on X-ray, CT or MRI
Elevated CRP or ESR and/or Inflammatory lesions in the sacroiliac joints and/or spine on MRI and/or Expert opiniona (Minimum 2 of 3 criteria)
United Kingdom n = 86 (12.1%) BASDAI ≥4
Modified New York criteria for AS
Spinal pain in last week 4/10 VAS
Hong Kong n = 61 (8.6%) BASDAI ≥4
Modified New York criteria for AS
Morning stiffness ≥45 min
Inflammatory back pain ≥40/100 VAS
Patient Global Assessment ≥40/100 VAS
  1. CT computerized tomography, MRI magnetic resonance imaging, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, AS ankylosing spondylitis, CRP C-reactive protein, ESR erythrocyte sedimentation rate, SJ sacroiliac joint, VAS visual analogue scale
  2. aPositive expert opinion defined in the analysis as Physician’s Global Assessment ≥4
  3. bNA at baseline, values reported for month 6